Johnson & Johnson’s Recalled Drugs Delayed Again

Health care giant Johnson & Johnson said Tuesday that consumers may have to wait until the end of the year before local stores shelves start to fill up again with the company’s recalled children’s Tylenol, Motrin and Bendryl.

Johnson & Johnson had hoped to restock retailers with all the recalled medications by the middle of 2011, but company executives said Tuesday that retailers will not received adequate supplies until the later half of the year, which is “slightly later than expected.”

Though Baron & Budd is not currently handling any cases regarding Johnson & Johnson’s recalled pharmaceuticals, the firm is a leader in litigation surrounding the recall of the DePuy hip implant system, made by a subsidiary of Johnson & Johnson.

The firm is also involved in litigation surrounding the diabetes drug Avandia, anti-depression medication Paxil, Reglan, Fosamax and others.